Thermo Fisher Scientific Rheinfelden
News
U.S. FDA grants Breakthrough Therapy Designation to Innate Pharma’s lacutamab for relapsed or refractory...
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Innate Pharma's lacutamab, an anti-KIR3DL2 cytotoxicity-inducing antibody, for the treatment...
Bavarian Nordic’s Chikungunya vaccine receives U.S. FDA approval for those aged 12 and older
The U.S. Food and Drug Administration (FDA) has approved Bavarian Nordic's VIMKUNYA (Chikungunya Vaccine, Recombinant) for injection, the first virus-like particle (VLP) single-dose chikungunya...
European Commission approves CSL’s ANDEMBRY for the prevention of recurrent attacks of hereditary angioedema
The European Commission (EC) has approved CSL's ANDEMBRY (garadacimab), the first and only once-monthly treatment targeting factor XIIa to prevent attacks of hereditary angioedema (HAE)...
